Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN ...

I asked the rheumatologist if it could be linked to the Pfizer vaccine and booster, and she said, ‘Yes, and you’re not the only patient I have who’s had this sequence of ...

Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...

IMUNON (IMNN) announced new safety and immunogenicity data from ongoing analyses of results from the Company’s first Phase 1 proof-of-concept ...

mRNA vaccination against SARS-CoV-2 was tied to a 57% and 73% lower risk of having at least one or two long-COVID symptoms, ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

In the early, uncertain days of the coronavirus pandemic, scientists delivered one comforting pronouncement: The virus that ...

A total of 13.6% of participants reported at least one symptom at 90 days. Among those in COVID-19 households, 15.6% of COVID ...

Covid vaccinations may not be enough to protect immunocompromised people from infection even when they have generated ...

Megyn Kelly made some big claims on her latest podcast episode on Wednesday, claiming that the Pfizer COVID vaccine left her with an auto-immune disorder. The 54-year-old stated t ...